A panel of experts advising the Food and Drug Administration will weigh the safety and effectiveness of the COVID-19 vaccine from Pfizer and BioNTech in a daylong public meeting. The committee will vote on whether the FDA should authorize the vaccine for emergency use during the pandemic.
The public meeting began at approximately 9 a.m. and will continue throughout the day. In-depth panel discussion is scheduled to start a little after 3 p.m. EST and will culminate in votes on questions posed by the FDA. The meeting is set to adjourn by 5:15 p.m.
